EUVIMEDEUVIMED entdecken
Crossref

Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema

Hasan Burhanettin Kaptı

Journal of Retina-Vitreous · 2026 · 35 (2) · 138

DOI: 10.37845/ret.vit.2026.35.18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Retina-Vitreous, 2026. Verfasst von Hasan Burhanettin Kaptı.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kaptı, H. B. (2026). Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema. Journal of Retina-Vitreous, 35(2), 138. https://doi.org/10.37845/ret.vit.2026.35.18

Vancouver

Kaptı HB. Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema. Journal of Retina-Vitreous. 2026;35(2):138. doi:10.37845/ret.vit.2026.35.18

BibTeX
@article{Kapt2026,
  author = {Kaptı, Hasan Burhanettin},
  title = {Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema},
  journal = {Journal of Retina-Vitreous},
  year = {2026},
  volume = {35},
  number = {2},
  pages = {138},
  doi = {10.37845/ret.vit.2026.35.18}
}
Kostenlos starten →